Company Data

Inhibitor Therapeutics Inc

Ticker
INTI
Current Price
$0.065925
Market Cap
$11.4M
Price Target
Refer to Report
52wk Range
$0.042 - $0.1376
Advanced Market Data

Overview

Inhibitor Therapeutics Inc is a pharmaceutical development company focused on developing and commercializing therapies for patients with cancer and non-cancerous proliferation disorders. The company’s main focus is to advance its lead product, SUBA-Itraconazole a patented, oral formulation of the currently marketed, well-understood, anti-fungal drug, Itraconazole, for prostate and lung cancer.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy